Tag: CORO
FDA Approves Updated Novavax COVID-19 Vaccine
Updated shot is expected to better target variants that are circulating now and help prevent hospitalization and death from the virus
Maternal Psychosocial Stress, COVID-19 Infection Tied to Infant Attentional Processing
Findings revealed lower infant attention scores at six months, which predicted socioemotional function, neurodevelopmental risk
Maternal COVID-19 Vaccination Provides Some Protection for Infants
Some protection against COVID-19-related hospitalizations seen among infants, especially those aged younger than 3 months
Infection With Omicron Less Likely to Result in Post-COVID-19 Condition
No variation in risk for PCC seen based on number of vaccinations, but previous infection linked to reduced PCC risk
BNT162b2 Vaccination Linked to Lower Risk for COVID-19 Encounters in Children Under 5
Vaccination linked to reduced odds ratio of COVID-19-related emergency department or urgent care encounter, outpatient visits
Immune Response Not Inferior With Coadministration of COVID-19, Flu Shots
Similar immune response and no increase in rate of reactogenicity events seen with coadministration versus COVID-19 vaccine alone
CDC Panel Gives Support to New COVID-19 Booster Shots
New booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating
FDA Approves New COVID-19 Booster Shots
New booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating
In Situ, Invasive Melanoma Diagnoses Decreased in 2020
Significant decrease seen in incidence of stage I melanomas but not other stages
FDA Approval of New COVID-19 Boosters Could Come by Friday
The new booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating
